The importance of pairwise interactions between peptide residues in the delineation of TCR specificity. NLM AIDSLINE Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


The importance of pairwise interactions between peptide residues in the delineation of TCR specificity.

J Immunol. 1998 Nov 1;161(9):4728-35. Unique Identifier : AIDSLINE MED/99008534
Leggatt GR; Hosmalin A; Pendleton CD; Kumar A; Hoffman S; Berzofsky JA; Molecular Immunogenetics and Vaccine Research Section, Metabolism; Branch, National Cancer Institute, National Institutes of Health,; Bethesda, MD 20892-1578, USA.


Abstract: A minimal, nonamer epitope (TEMEKEGKI) from the reverse transcriptase protein of HIV-1, restricted by H-2Kk, was identified and the function of individual residues determined. Besides classical anchor residues at positions 2 and 9, methionine at position 3 was identified as an important MHC anchor and improved binding of a different (malarial) nonamer epitope to H-2Kk, albeit while also abolishing CTL recognition. Lysine at position 5 was replaceable by alanine for CTL raised against wild-type peptide but abolished recognition for CTL raised against the variant 5ALA peptide, indicating a unidirectional cross-reactivity. Interestingly, one CTL line raised against the 5ALA substituted peptide was permissive for a double substitution at positions 5 and 6, in which lysine was permissive at position 5 only if the adjacent glutamic acid was replaced by alanine. Extensive analysis revealed three distinct patterns of responses with peptides doubly substituted in this region: recognition of both single substitutions but not the double substitution, recognition of only one single substitution but also the double substitution, or recognition of both single substitutions and the double substitution. A second complementary substitution can therefore restore function lost through a first substitution. Thus, no residue acts independently of its neighbors, and pairs of substitutions may give results not predictable from the effects of each taken singly. This finding may have bearing on viral infections (such as HIV), in which the accumulation of two mutations in the epitope may lead to the reengagement of memory CTL previously silenced by the initial mutation.
Keywords: JOURNAL ARTICLE Amino Acid Substitution Animal Chemistry, Physical Comparative Study Cross Reactions Epitopes/CHEMISTRY/GENETICS/IMMUNOLOGY H-2 Antigens/*IMMUNOLOGY HIV-1/IMMUNOLOGY HIV-1 Reverse Transcriptase/CHEMISTRY/GENETICS/*IMMUNOLOGY L Cells (Cell Line) Mice Mice, Inbred C3H Oligopeptides/CHEMISTRY/CHEMICAL SYNTHESIS/IMMUNOLOGY Plasmodium falciparum/IMMUNOLOGY Protein Binding Protein Conformation Protozoan Proteins/CHEMISTRY/*IMMUNOLOGY Receptors, Antigen, T-Cell/*CHEMISTRY/IMMUNOLOGY/METABOLISM T-Lymphocytes, Cytotoxic/*IMMUNOLOGYKWDjournalarticleaminoacidsubstitutionanimalchemistry,physicalcomparativestudycrossreactionsepitopes/chemistry/genetics/immunologyh-2antigens/KWDimmunologyhiv-1/immunologyhiv-1reversetranscriptase/chemistry/genetics/KWDimmunologylcells(cellline)micemice,inbredc3holigopeptides/chemistry/chemicalsynthesis/immunologyplasmodiumfalciparum/immunologyproteinbindingproteinconformationprotozoanproteins/chemistry/KWDimmunologyreceptors,antigen,t-cell/KWDchemistry/immunology/metabolismt-lymphocytes,cytotoxic/KWDimmunology
990130
A9910558

Copyright © 1999 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .